Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK

News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Merck KGaA : Announces Application Period for Start-ups

07/30/2015 | 11:06am US/Eastern


News Release Leonie Prigge +49 6151 72-5047 30. July 2015 Merck Announces Application Period for Start-ups

Candidates can apply until August 14, 2015

Merck donates € 25,000 as a silent participant to the start-ups

Darmstadt, Germany, July 30, 2015 - Merck, a leading company for innovative, top- quality high-tech products in healthcare, life science and performance materials, is calling for national and international start-ups to apply for funding of innovative ideas by August 14, 2015.
The Accelerator program is aimed at young companies in the healthcare, life science, performance materials, and IT sectors. The program will run for three months, in which at least three selected start-ups will receive strategic and operational advice, as well as financial support of € 25,000 in the form of a silent participation. The program does not foresee an equity interest in the companies receiving funding, nor influence over their operational and strategic management. The first three start-ups are supposed to move into the newly built, modular Innovation Center in Darmstadt, from September 14, 2015, on.
In addition to providing financial and infrastructure assistance, Merck will offer to coach the start-ups also supported by mentors and enable them to participate in several trainings. At the end of the three months, the companies will be part of Merck's start-up

Merck KGaA

Frankfurter Strasse 250 Head of Media Relations -62445

64293 Darmstadt Spokesperson: -9591 / -7144 / -6328

Hotline +49 6151 72-5000 Fax +49 6151 72-3138 www.merckgroup.commedia.relations@merckgroup.com

Page 1 of 2

News Release

"Building up an alumni network is one of the long-term goals," said Michael Gamber, who heads Merck's Innovation Center. "We want to provide a home for our start-ups, also beyond the Accelerator program, and continue to collaborate closely with them."
Interested parties can find more information on this website and apply until August 14.

All Merck news releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe, to register online, change your selection or discontinue this service.

Merck is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses - Merck Serono, Consumer Health, Allergopharma, Biosimilars, Merck Millipore and Performance Materials - and generated total revenues of around € 11.3 billion in 2014. Around 39,000 employees work in 66 countries to improve the quality of life for patients, to further the success of customers, and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company - since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company operates as EMD Serono, EMD Millipore and EMD Performance Materials.

Page 2 of 2

distributed by
React to this article
Latest news on MERCK KGAA
11:06a MERCK KGAA : Announces Application Period for Start-ups
04:06a MERCK KGAA : Appoints Isabel De Paoli as new Head of Group Communications
07/29 MERCK KGAA : Aeterna Zentaris Enters into Agreement with EMD Serono
07/25 MERCK KGAA : Serono extends collaboration with BioMed X
07/25 MERCK KGAA : Serono extends collaboration with BioMed X
07/23 MERCK KGAA : Trademark Application for "E.R.A." Filed by Merck KGaA
07/23 MERCK KGAA : Serono and BioMed X Extend Collaboration
07/23 MERCK KGAA : Serono Chooses Genedata Biologics to Streamline Antibody Discovery ..
07/22 MERCK KGAA : Serono Chooses Genedata Biologics to Streamline Antibody Discovery ..
07/21 MERCK KGAA : Serono Awards € 20,000 to Innovation Cup Winners
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
More Financials